Heron Therapeutics (HRTX) Current Deferred Revenue (2009 - 2018)
Heron Therapeutics' Current Deferred Revenue came in at $14.01 million for Q4 2018, up 407.1% from $2.76 million a year earlier and up 33.1% from the prior quarter.
Powered by 
Analysis
Heron Therapeutics (HRTX) Current Deferred Revenue (2009 - 2018) Analysis & Trends
Going back to Q4 2010, Heron Therapeutics' Current Deferred Revenue data covers 10 quarters.
- Going back by year, Current Deferred Revenue was $2.76 million in FY2017 (+151.4%) and $1.1 million in FY2016.
- The Q4 2018 figure represents the highest quarterly Current Deferred Revenue in data going back to Q4 2010.
- Year-over-year, Current Deferred Revenue has increased for three consecutive quarters, with growth averaging 137.9% over the last five quarters.
- Business Quant data shows HRTX's Current Deferred Revenue at $10.52 million (Q3 2018), $9.44 million (Q2 2018) and $2.35 million (Q1 2018) in the three quarters before Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Heron Therapeutics | 70.40 Mn | -87.13 Mn | 26.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 14.01 Mn |
| Sep 30, 2018 | 10.52 Mn |
| Jun 30, 2018 | 9.44 Mn |
| Mar 31, 2018 | 2.35 Mn |
| Dec 31, 2017 | 2.76 Mn |
| Sep 30, 2017 | 5.56 Mn |
| Jun 30, 2017 | 4.79 Mn |
| Mar 31, 2017 | 5.24 Mn |
| Dec 31, 2016 | 1.10 Mn |
| Mar 31, 2011 | 212,000.00 |
| Dec 31, 2010 | 237,000.00 |
| Sep 30, 2010 | 95,000.00 |
| Jun 30, 2010 | 112,000.00 |
| Mar 31, 2010 | 115,000.00 |
| Dec 31, 2009 | 92,000.00 |
| Sep 30, 2009 | 220,000.00 |
| Jun 30, 2009 | 1.00 Mn |
| Mar 31, 2009 | 1.00 Mn |
API Access
Heron Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();